甘油三酯葡萄糖指数在2型糖尿病前期中的研究作用
The Research Role of Triglyceride Glucose Index in Pre-Type 2 Diabetes
DOI: 10.12677/ACM.2023.1371648, PDF,   
作者: 徐士博:青海大学研究生院,青海 西宁;赵成玉*:青海大学附属医院老年医学科,青海 西宁
关键词: 甘油三酯葡萄糖指数胰岛素抵抗2型糖尿病前期Triglyceride Glucose Index Insulin Resistance Pre-Type 2 Diabetes
摘要: 2型糖尿病是一种以胰岛素抵抗和血糖持续升高为主要特征的内分泌疾病,随着病情的发展患者可出现不同程度的并发症,如视网膜病变、心血管病变、周围神经病变、糖尿病肾病等。该疾病主要以多尿、多饮、多食、体重减轻为主要临床表现,出现上述症状时通常早已达到2型糖尿病的诊断标准。故疾病的筛查在高危人群中便显得十分重要,胰岛素抵抗通常作为2型糖尿病的主要特征出现在我们的视野,甚至常于2型糖尿病发生前便已存在,患病前明确胰岛素抵抗的存在与否及程度对2型糖尿病的诊断具有重要价值。甘油三酯葡萄糖指数(TyG)是由空腹血浆葡萄糖和甘油三酯两个指标计算而得出的指数,该指数已被明确可作为胰岛素抵抗(IR)的替代生物标志物。本文将以甘油三酯葡萄糖指数与2型糖尿病前期的相关性进行叙述,为病变的早期预防提供一些参考。
Abstract: Type 2 diabetes mellitus is an endocrine disease characterized by insulin resistance and continuous rise of blood sugar. With the development of the disease, patients may develop complications of varying degrees, such as retinopathy, cardiovascular disease, peripheral neuropathy, diabetic nephropathy, etc. The main clinical manifestations of this disease are polyuria, polydipsia and weight loss. When these symptoms appear, the diagnostic criteria of type 2 diabetes are usually al-ready met. Therefore, disease screening is very important in high-risk groups. Insulin resistance usually appears in our field of vision as the main feature of type 2 diabetes, and even exists before the onset of type 2 diabetes. The existence and degree of insulin resistance before the onset of type 2 diabetes is of great value for the diagnosis of type 2 diabetes. Triglyceride glucose index (TyG) is an index calculated by fasting plasma glucose and triglyceride, which has been clearly used as an alternative biomarker for insulin resistance (IR). This article will describe the correlation between triglyceride glucose index and pretype 2 diabetes, so as to provide some references for the early prevention of lesions.
文章引用:徐士博, 赵成玉. 甘油三酯葡萄糖指数在2型糖尿病前期中的研究作用[J]. 临床医学进展, 2023, 13(7): 11762-11767. https://doi.org/10.12677/ACM.2023.1371648

参考文献

[1] 中国2型糖尿病防治指南(2020年版) (上) [J]. 中国实用内科杂志, 2021, 41(8): 668-695.
[2] Yang, S.H., Dou, K.F. and Song, W.J. (2010) Prevalence of Diabetes among Men and Women in China. The New England Journal of Medicine, 362, 2425-2426. [Google Scholar] [CrossRef
[3] Echouffo-Tcheugui, J.B., Perreault, L., Ji, L. and Dagogo-Jack, S. (2023) Diagnosis and Management of Prediabetes: A Review. JAMA, 329, 1206-1216. [Google Scholar] [CrossRef] [PubMed]
[4] Massimino, M., Monea, G., Marinaro, G., Rubino, M., Mancuso, E., Mannino, G.C., et al. (2022) The Triglycerides and Glucose (TyG) Index Is Associated with 1-Hour Glucose Levels during an OGTT. International Journal of Environmental Research and Public Health, 20, Article No. 787. [Google Scholar] [CrossRef] [PubMed]
[5] Mohd Nor, N.S., Lee, S., Bacha, F., Tfayli, H. and Arslanian, S. (2016) Triglyceride Glucose Index as a Surrogate Measure of Insulin Sensitivity in Obese Adolescents with Normogly-cemia, Prediabetes, and Type 2 Diabetes Mellitus: Comparison with the Hyperinsulinemic-Euglycemic Clamp. Pediatric Diabetes, 17, 458-465. [Google Scholar] [CrossRef] [PubMed]
[6] Song, D.K., Lee, H., Sung, Y.A. and Oh, J.Y. (2016) Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome. Yonsei Medical Journal, 57, 1404-1411. [Google Scholar] [CrossRef] [PubMed]
[7] Lee, S.-H., Park, S.-Y. and Choi, C.S. (2022) Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes & Metabolism Journal, 46, 15-37. [Google Scholar] [CrossRef] [PubMed]
[8] 赵茜, 张巧. 新诊断2型糖尿病患者胰岛素抵抗指数、空腹甘油三酯及葡萄糖简易指数、空腹血糖/空腹胰岛素与正常血糖高胰岛素钳夹试验的一致性分析[J]. 中国糖尿病杂志, 2017, 25(12): 1083-1085.
[9] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guer-rero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[10] Guerrero-Romero, F., Simental-Mendía, L.E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M.G., Hernández-González, S.O., et al. (2010) The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. The Jour-nal of Clinical Endocrinology & Metabolism, 95, 3347-3351. [Google Scholar] [CrossRef] [PubMed]
[11] Lee, E.Y., Yang, H.K., Lee, J., Kang, B., Yang, Y., Lee, S.-H., et al. (2016) Triglyceride Glucose Index, a Marker of Insulin Re-sistance, Is Associated with Coronary Artery Stenosis in Asymptomatic Subjects with Type 2 Diabetes. Lipids in Health and Disease, 15, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
[12] da Silva, A., Caldas, A.P.S., Hermsdorff, H.H.M., Bersch-Ferreira, Â.C., Torreglosa, C.R., Weber, B., et al. (2019) Triglyceride-Glucose Index Is Associated with Symptomatic Coronary Artery Disease in Patients in Secondary Care. Cardiovascular Diabetology, 18, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
[13] Yang, K. and Liu, W. (2021) Triglyceride and Glucose Index and Sex Differences in Relation to Major Adverse Cardiovascular Events in Hypertensive Patients without Diabetes. Frontiers in Endocrinology (Lausanne), 12, Article ID: 761397. [Google Scholar] [CrossRef] [PubMed]
[14] Ruan, G.-T., Xie, H.-L., Zhang, H.-Y., Liu, C.-A., Ge, Y.-Z., Zhang, Q., et al. (2022) A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients with Cancer. Frontiers in Endocrinology (Lausanne), 13, Article ID: 905266. [Google Scholar] [CrossRef] [PubMed]
[15] Fritz, J., Brozek, W., Concin, H., Nagel, G., Kerschbaum, J., Lhotta, K., et al. (2021) The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Aus-trian Adults. JAMA Network Open, 4, e212612. [Google Scholar] [CrossRef] [PubMed]
[16] Zhou, S., Yu, Y., Zhang, Z., Ma, L., Wang, C., Yang, M., et al. (2022) Association of Obesity, Triglyceride-Glucose and Its Derivatives Index with Risk of Hyperuricemia among College Students in Qingdao, China. Frontiers in Endocrinology (Lausanne), 13, Article ID: 1001844. [Google Scholar] [CrossRef] [PubMed]
[17] Zou, S., Yang, C., Shen, R., Wei, X., Gong, J., Pan, Y., et al. (2021) Association between the Triglyceride-Glucose Index and the Incidence of Diabetes in People with Different Phe-notypes of Obesity: A Retrospective Study. Frontiers in Endocrinology (Lausanne), 12, Article ID: 784616. [Google Scholar] [CrossRef] [PubMed]
[18] Selvi, N.M.K., Nandhini, S., Sakthivadivel, V., Lokesh, S., Srini-vasan, A.R. and Sumathi, S. (2021) Association of Triglyceride-Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes Mellitus. Maedica (Bucur), 16, 375-381. [Google Scholar] [CrossRef] [PubMed]
[19] Yang, T., Liu, Y., Li, L., Zheng, Y., Wang, Y., Su, J., et al. (2022) Correlation between the Triglyceride-to-High-Den- sity Lipoprotein Cholesterol Ratio and Other Unconventional Lipid Parameters with the Risk of Prediabetes and Type 2 Diabetes in Patients with Coronary Heart Disease: A RCSCD-TCM Study in China. Cardiovascular Diabetology, 21, Article No. 93. [Google Scholar] [CrossRef] [PubMed]
[20] Tohidi, M., Asgari, S., Chary, A., Safiee, S., Azizi, F. and Ha-daegh, F. (2023) Association of Triglycerides to High- Density Lipoprotein Cholesterol Ratio to Identify Future Predia-betes and Type 2 Diabetes Mellitus: Over One-Decade Follow-Up in the Iranian Population. Diabetology Metabolic Syn-drome, 15, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[21] Guo, W., Qin, P., Lu, J., Li, X., Zhu, W., Xu, N., et al. (2019) Diagnostic Values and Appropriate Cutoff Points of Lipid Ratios in Patients with Abnormal Glucose Tolerance Status: A Cross-Sectional Study. Lipids in Health and Disease, 18, Article No. 130. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, Y., Wang, M., Zuo, Y., Su, X., Wen, J., Zhai, Q., et al. (2022) Comparison of the Predictive Power of Adiposity Indices and Blood Lipid Indices for Diagnosis of Prediabetes. Hormones (Athens), 21, 683-690. [Google Scholar] [CrossRef] [PubMed]
[23] Li, J., Zou, B., Yeo, Y.H., Feng, Y., Xie, X., Lee, D.H., et al. (2019) Prevalence, Incidence, and Outcome of Non-Al- coholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology and Hepatology, 4, 389-398. [Google Scholar] [CrossRef
[24] Muzica, C.M., Sfarti, C., Trifan, A., Zenovia, S., Cuciureanu, T., Nastasa, R., et al. (2020) Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relation-ship. Canadian Journal of Gastroenterology and Hepatology, 2020, Article ID: 6638306. [Google Scholar] [CrossRef] [PubMed]
[25] Fujii, H., Imajo, K., Yoneda, M., Nakahara, T., Hyogo, H., Takahashi, H., et al. (2019) HOMA-IR: An Independent Predictor of Advanced Liver Fibrosis in Nondiabetic Non-Alcoholic Fatty Liver Disease. Journal of Gastroenterology and Hepatology, 34, 1390-1395. [Google Scholar] [CrossRef] [PubMed]
[26] Zhang, S., Du, T., Zhang, J., Lu, H., Lin, X., Xie, J., et al. (2017) The Tri-glyceride and Glucose Index (TyG) Is an Effective Biomarker to Identify Nonalcoholic Fatty Liver Disease. Lipids in Health and Disease, 16, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[27] Song, S., Son, D.-H., Baik, S.-J., Cho, W.-J. and Lee, Y.-J. (2022) Triglyceride Glucose-Waist Circumference (TyG- WC) Is a Reliable Marker to Predict Non-Alcoholic Fatty Liver Dis-ease. Biomedicines, 10, Article No. 2251. [Google Scholar] [CrossRef] [PubMed]
[28] Beran, A., Ayesh, H., Mhanna, M., Wahood, W., Ghazaleh, S., Abuhelwa, Z., et al. (2022) Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Me-ta-Analysis of 121,975 Individuals. Journal of Clinical Medicine, 11, Article No. 2666. [Google Scholar] [CrossRef] [PubMed]
[29] Kim, K.-S., Hong, S., Ahn, H.-Y. and Park, C.-Y. (2022) Triglyceride and Glucose Index Is a Simple and Easy-to- Calculate Marker Associated with Nonalcoholic Fatty Liver Disease. Obesity (Silver Spring), 30, 1279-1288. [Google Scholar] [CrossRef] [PubMed]
[30] KDIGO (2020) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 98, S1-S115. [Google Scholar] [CrossRef] [PubMed]
[31] Dong, J., Yang, H., Zhang, Y., Chen, L. and Hu, Q. (2022) A High Triglyceride Glucose Index Is Associated with Early Renal Impairment in the Hypertensive Patients. Frontiers in Endo-crinology (Lausanne), 13, Article ID: 1038758. [Google Scholar] [CrossRef] [PubMed]
[32] Gao, Y.-M., Chen, W.-J., Deng, Z.-L., Shang, Z. and Wang, Y. (2023) Association between Triglyceride-Glucose Index and Risk of End-Stage Renal Disease in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease. Frontiers in Endocrinology (Lausanne), 14, Article ID: 1150980. [Google Scholar] [CrossRef] [PubMed]
[33] Rosenblit, P.D. (2019) Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition. Current Diabetes Reports, 19, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[34] Wang, T., Li, M., Zeng, T., Hu, R., Xu, Y., Xu, M., et al. (2022) Association between Insulin Resistance and Cardio- vascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study. Diabetes Care, 45, 1863-1872. [Google Scholar] [CrossRef] [PubMed]
[35] Peng, N., Kuang, M., Peng, Y., Yu, H., Zhang, S., Xie, G., et al. (2023) Associations between TyG-BMI and Normal- High Blood Pressure Values and Hypertension: Cross-Sectional Evidence from a Non-Diabetic Population. Frontiers in Cardiovascular Medicine, 10, Article ID: 1129112. [Google Scholar] [CrossRef] [PubMed]
[36] Zhao, J., Fan, H., Wang, T., Yu, B., Mao, S., Wang, X., et al. (2022) TyG Index Is Positively Associated with Risk of CHD and Coronary Atherosclerosis Severity among NAFLD Patients. Cardiovascular Diabetology, 21, Article No. 123. [Google Scholar] [CrossRef] [PubMed]
[37] Sajdeya, O., Beran, A., Mhanna, M., Alharbi, A., Burmeister, C., Abuhelwa, Z., et al. (2022) Triglyceride Glucose Index for the Prediction of Subclinical Atherosclerosis and Arterial Stiffness: A Meta-Analysis of 37,780 Individuals. Current Problems in Cardiology, 47, Article ID: 101390. [Google Scholar] [CrossRef] [PubMed]
[38] Wang, L., Cong, H.-L., Zhang, J.-X., Hu, Y.-C., Wei, A., Zhang, Y.-Y., et al. (2020) Triglyceride-Glucose Index Predicts Adverse Cardiovascular Events in Patients with Diabetes and Acute Coronary Syndrome. Cardiovascular Diabetology, 19, Article No. 80. [Google Scholar] [CrossRef] [PubMed]
[39] Cai, X., Zhang, Y., Li, M., Wu, J.H., Mai, L., Li, J., et al. (2020) Association between Prediabetes and Risk of All Cause Mortality and Cardiovascular Disease: Updated Meta-Analysis. BMJ, 370, m2297. [Google Scholar] [CrossRef] [PubMed]
[40] White, N.H., Pan, Q., Knowler, W.C., Schroeder, E.B., Dabelea, D., Chew, E.Y., et al. (2022) Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience. Diabetes Care, 45, 2653-2661. [Google Scholar] [CrossRef] [PubMed]
[41] Fritsche, A., Wagner, R., Heni, M., Kantartzis, K., Machann, J., Schick, F., et al. (2021) Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS). Diabetes, 70, 2785-2795. [Google Scholar] [CrossRef] [PubMed]